GEODE CAPITAL MANAGEMENT, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$5,211,000
-10.2%
98,647
+4.1%
0.00%0.0%
Q2 2020$5,806,000
+9.0%
94,760
+0.7%
0.00%0.0%
Q1 2020$5,325,000
-49.1%
94,143
-48.8%
0.00%0.0%
Q4 2019$10,468,000
+104.1%
183,852
+91.8%
0.00%0.0%
Q3 2019$5,128,000
-13.3%
95,840
-3.2%
0.00%0.0%
Q2 2019$5,914,000
+15.6%
99,052
+20.6%
0.00%0.0%
Q1 2019$5,117,000
-37.9%
82,106
-39.6%
0.00%0.0%
Q4 2018$8,242,000
+120.3%
136,034
+112.7%
0.00%0.0%
Q3 2018$3,741,000
+29.2%
63,961
-0.9%
0.00%0.0%
Q2 2018$2,895,000
+11.1%
64,550
+9.8%
0.00%0.0%
Q1 2018$2,606,000
+2.0%
58,791
-0.3%
0.00%0.0%
Q4 2017$2,554,000
+2.1%
58,963
+9.6%
0.00%0.0%
Q3 2017$2,502,000
-11.8%
53,803
-6.1%
0.00%0.0%
Q2 2017$2,836,000
-21.6%
57,303
-13.3%
0.00%0.0%
Q1 2017$3,619,000
+14.8%
66,059
+16.7%
0.00%0.0%
Q4 2016$3,152,000
+42.0%
56,597
+16.4%
0.00%0.0%
Q3 2016$2,220,000
+34.0%
48,630
+17.2%
0.00%0.0%
Q2 2016$1,657,000
+16.0%
41,498
+1.1%
0.00%0.0%
Q1 2016$1,428,000
-4.3%
41,039
+18.2%
0.00%0.0%
Q4 2015$1,492,000
-5.9%
34,731
-4.7%
0.00%0.0%
Q3 2015$1,586,000
-12.3%
36,440
+3.9%
0.00%0.0%
Q2 2015$1,809,000
+37.5%
35,069
+4.3%
0.00%0.0%
Q1 2015$1,316,000
+12.4%
33,631
+10.9%
0.00%0.0%
Q4 2014$1,171,000
+42.5%
30,327
+30.2%
0.00%0.0%
Q3 2014$822,000
+44.5%
23,291
+10.2%
0.00%
Q2 2014$569,000
+45.5%
21,130
+39.8%
0.00%
Q1 2014$391,000
+15.7%
15,119
-3.2%
0.00%
Q4 2013$338,000
+11.2%
15,624
+0.2%
0.00%
Q3 2013$304,000
+25.1%
15,592
-0.1%
0.00%
Q2 2013$243,00015,6000.00%
Other shareholders

There were no reported owners of BIOSPECIFICS TECHNOLOGIES CO in Q4 2020.

NameSharesValueWeighting ↓
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders